Domov › Burkittov limfom › Georgia › Atlanta

Klinične študije za Burkittov limfom v Atlanta, GA

12 študij za Burkittov limfom išče udeležence na lokacijah v Atlanta in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

366 Days – 46 Years · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 3

Emory University Hospital/Winship Cancer Institute, Atlanta

Starost 18–39 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT03150693

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Vključevanje udeležencevOpazovalna študija

Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta

Starost 0–38 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06131801

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 2

Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Vključevanje udeležencevFaza 2

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

365 Days · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06317662

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 1

Winship Cancer Institute Emory University, Atlanta
Northside Hospital Cancer Institute, Atlanta

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

Starost 1–30 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Vključevanje udeležencevFaza 3

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

365 Days – 25 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Vključevanje udeležencevFaza 1/2

Research Site, Atlanta

Starost 12 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT06137118

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Vključevanje udeležencevFaza 2

Children's Healthcare of Atlanta at Egleston, Atlanta

Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Vključevanje udeležencevFaza 1

Winship Cancer Institute, Emory University, Atlanta

Starost 18 in več · Vsi spoli · Posodobljeno 5. nov. 2025 · NCT04260022

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Vključevanje udeležencevFaza 2

Children's Healthcare of Atlanta, Atlanta

Starost 1–25 · Vsi spoli · Posodobljeno 4. maj 2025 · NCT03509961

Študije za Burkittov limfom v drugih mestih

Druge študije v Atlanta

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.